Novel roles of iRhom2 in the regulation of adiposity and inflammation in diet-induced obesity
Abstract
Details
- Title: Subtitle
- Novel roles of iRhom2 in the regulation of adiposity and inflammation in diet-induced obesity
- Creators
- Joseph Skurski
- Contributors
- Thorsten Maretzky (Advisor)Noah Butler (Committee Member)Prajwal Gurung (Committee Member)Brian O'Neill (Committee Member)Jerrold Weiss (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Immunology
- Date degree season
- Summer 2021
- Publisher
- University of Iowa
- DOI
- 10.17077/etd.005862
- Number of pages
- xiv, 143 pages
- Copyright
- Copyright 2021 Joseph Skurski
- Comment
- This thesis has been optimized for improved web viewing. If you require the original version, contact the University Archives at the University of Iowa: https://www.lib.uiowa.edu/sc/contact/
- Language
- English
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (pages 134-143).
- Public Abstract (ETD)
Obesity, defined by excessive weight gain, is a chronic disease which has become increasingly common in recent decades. Obesity is often accompanied by other types of chronic conditions, including inflammation of the fat tissue, and resistance to insulin. Although the development of inflammation and metabolic complications are common consequences of obesity, we do not completely understand the relationship between inflammation and insulin resistance. Data from mouse studies have shown that the inflammation that develops with obesity can be attributed to immune cells (macrophages in particular) that produce a key inflammatory molecule, tumor necrosis factor (TNF). Unfortunately, the elimination of TNF activity alone has not been enough to restore insulin resistance in diabetic patients, suggesting that other factors contribute to disease.
The release of TNF from macrophages is regulated by molecules ADAM17 and iRhom2, which also control the release of tissue growth factors in the epidermal growth factor receptor (EGFR) pathway. The goal of this dissertation is to understand how ADAM17/iRhom2 contribute to inflammation and metabolic dysregulation in obesity. We found that the genetic removal of iRhom2 leads to increased weight gain, but lessened inflammation in mice fed a high-fat diet. Insulin resistance is worsened in these mice, suggesting that inflammation in the fat tissue is not necessary for the development of insulin resistance, and that these two complications are driven by different molecular causes. We also found that TNF can be amplified by iRhom2 when there is very little inflammatory stimulus present, and that other inflammatory molecules can be regulated by TNF. In addition, we observed that EGFR activity driven by iRhom2 plays an important role in the ability of stem cells to become fat cells, and that the fat cells which manage to develop are excessively large. Taken together, this dissertation shows for the first time that iRhom2 activity in immune cells plays a role in weight gain, inflammation in the fat tissue, and the development of insulin resistance in response to a long-term high-fat diet.
- Academic Unit
- Immunology Graduate Program
- Record Identifier
- 9984124359802771